Checkpoint Inhibitors Market: What’s Next by 2033?
According to FutureWise analysis, the market for checkpoint inhibitors in 2023 is US$27.71 billion, and is expected to reach US$105.01 billion by 2031 at a CAGR of 18.10%. A checkpoint inhibitor is a type of medication that disables the proteins used by the body's immune system to prevent cancer cells from being destroyed. These medications are part of immunotherapy, which helps block the...
0 Commentarii 0 Distribuiri 256 Views 0 previzualizare
Sponsor